Literature DB >> 22505462

The clinical management of relatives of young sudden unexplained death victims; implantable defibrillators are rarely indicated.

Jane Caldwell1, Natalie Moreton, Naz Khan, Lauren Kerzin-Storrar, Kay Metcalfe, William Newman, Clifford J Garratt.   

Abstract

OBJECTIVE: Following national guidance on management of sudden unexplained death (SUD) in the young, inherited cardiac conditions (ICC) clinics were established to identify and treat relatives thought to be at increased risk. Studies have examined diagnostic yield of these clinics but outcome of clinical management has not been reported.
DESIGN: Observational outcome study of consecutively referred relatives of SUD victims.
SETTING: Regional ICC clinic. PATIENTS: 193 individuals (108 families) referred to a regional ICC clinic following SUD/aborted cardiac arrest of a young relative (mean follow-up 16.5 months, range 0.1-61).
INTERVENTIONS: All individuals underwent assessment by history, examination, ECG and echocardiography. Exercise electrocardiography, ajmaline provocation, further imaging techniques and genetic testing were performed in selected individuals. Implantable cardioverter-defibrillator (ICD) insertion based on national guidelines. MAIN OUTCOME MEASURES AND
RESULTS: Forty-five patients (23%) from 38 families (35%) were diagnosed with an inheritable cause of sudden death. Eighteen had potentially prognostically important medication commenced and 4 had an ICD inserted on clinic recommendation (2 hypertrophic cardiomyopathy, 1 dilated cardiomyopathy, 1 arrhythmogenic right ventricular cardiomyopathy). Two other individuals had ICDs removed after negative testing for familial RYR2 mutations. No deaths have occurred during follow-up to date.
CONCLUSION: A diagnosis of an inheritable cause of sudden death was obtained in a significant minority of those with a family history of SUD/aborted cardiac arrest. The number of ICDs inserted as a result of specialist assessment was very small (2%). A major function of the clinic is reassurance of the clinically normal and cessation of treatment after exclusion of familial disease by genetic testing.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22505462     DOI: 10.1136/heartjnl-2011-300924

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  4 in total

1.  Sudden Unexplained Death - Treating the Family.

Authors:  Greg Mellor; Elijah R Behr
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-11-29

Review 2.  Exercise: friend or foe?

Authors:  Frida J Dangardt; William J McKenna; Thomas F Lüscher; John E Deanfield
Journal:  Nat Rev Cardiol       Date:  2013-06-25       Impact factor: 32.419

3.  A novel cardiac ryanodine receptor gene (RyR2) mutation in an athlete with aborted sudden cardiac death: a case of adult-onset catecholaminergic polymorphic ventricular tachycardia.

Authors:  Junko Arakawa; Akira Hamabe; Takeshi Aiba; Tomoo Nagai; Mikoto Yoshida; Takumi Touya; Norio Ishigami; Hideki Hisadome; Shuichi Katsushika; Hirotsugu Tabata; Yoshihiro Miyamoto; Wataru Shimizu
Journal:  Heart Vessels       Date:  2014-08-05       Impact factor: 2.037

4.  Family-based associations in measures of psychological distress and quality of life in a cardiac screening clinic for inheritable cardiac diseases: a cross-sectional study.

Authors:  Catherine McGorrian; Charlene McShane; Colin McQuade; Ted Keelan; Jim O Neill; Joseph Galvin; Kevin Malone; Niall G Mahon; Mary Codd
Journal:  BMC Med Genet       Date:  2013-01-08       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.